Does peer-navigated linkage to care work? A cross-sectional study of active linkage to care within an integrated non-communicable disease-HIV testing centre for adults in Soweto, South Africa.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
05
2020
accepted:
07
10
2020
entrez:
22
10
2020
pubmed:
23
10
2020
medline:
15
12
2020
Statut:
epublish
Résumé
South Africa is the HIV epidemic epicentre; however, non-communicable diseases (NCDs) will be the most common cause of death by 2030. To improve identification and initiation of care for HIV and NCDs, we assessed proportion of clients referred and linked to care (LTC) for abnormal/positive screening results and time to LTC and treatment initiation from a HIV Testing Services (HTS) Centre before and after integrated testing for NCDs with optional peer-navigated linkage to care. This two-phase prospective study was conducted at an adult HTS Centre in Soweto, South Africa. Phase 1 (February-June 2018) utilised standard of care (SOC) HTS services (blood pressure [BP], HIV rapid diagnostic testing (RDT), sexually transmitted infections [STI]/Tuberculosis [TB] symptom screening) with passive referral for abnormal/positive results. Phase 2 (June 2018-March 2019) further integrated blood glucose/cholesterol/chlamydia RDT, with optional peer-navigated referral. Enrolled referred clients completed telephonic follow-up surveys confirming LTC/treatment initiation ≤3 months post-screening. Socio-demographics, screening results, time to LTC/treatment initiation, peer-navigated referral uptake were reported. Analysis included Fisher's exact, chi-squared, Kruskal Wallis, and Student's T-tests. Thematic analysis was conducted for open-ended survey responses. Of all 320 referrals, 40.0% were HIV-infections, 11.9% STIs, 6.6% TB, and 28.8% high/low BP. Of Phase 2-only referrals, 29.4% were for glucose and 23.5% cholesterol. Integrated NCD-HTS had significantly more clients LTC for HIV (76.7%[n = 66/86] vs 52.4%[n = 22/42], p = 0.0052) and within a shorter average time (6-8 days [Interquartile range (IQR):1-18.5] vs 8-13 days [IQR:2-32]) as compared to SOC HTS. Integrated NCD-HTS clients initiated HIV/STIs/BP treatment on average more quickly as compared to SOC HTS (5 days for STIs [IQR:1-21], 8 days for HIV/BP [IQR:5-17 and 2-13, respectively] vs 10 days for STIs [IQR: 4-32], 19.5 days for HIV [IQR:6.5-26.5], 8 days for BP [IQR:2-29)]. Participants chose passive over active referral (89.1% vs 10.9%; p<0.0001). Participants rejecting peer-navigated referral preferred to go alone (55.7% [n = 39/70]). Non-LTC was due to being busy (41.1% [n = 39/95]) and not being ready/refusing treatment (31.6% [n = 30/95]). Normalised results assessed at referral clinic (49.7% [n = 98/196]), prescribed lifestyle modification/monitoring (30.9% [n = 61/196]), and poor clinic flow/congestion and/or further testing required (10.7% [n = 21/196]) were associated with non-treatment initiation. Same-day treatment initiation is not achieved across diseases, despite peer-navigated referral. There are psychosocial and health systems barriers at entry to care/treatment initiation. Additional research may identify best strategies for rapid treatment initiation.
Identifiants
pubmed: 33091093
doi: 10.1371/journal.pone.0241014
pii: PONE-D-20-14791
pmc: PMC7580918
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0241014Subventions
Organisme : FIC NIH HHS
ID : K43 TW010698
Pays : United States
Organisme : PEPFAR
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
AIDS Care. 2001 Dec;13(6):693-708
pubmed: 11720640
Clin Infect Dis. 2017 Jan 15;64(2):132-133
pubmed: 27965300
J Int AIDS Soc. 2014 Aug 01;17:19032
pubmed: 25095831
PLoS Med. 2011 Jul;8(7):e1001056
pubmed: 21811403
J Health Care Poor Underserved. 2008 Aug;19(3):912-25
pubmed: 18677078
PLoS One. 2018 Jun 21;13(6):e0199602
pubmed: 29928044
AIDS Behav. 2014 Aug;18(8):1501-10
pubmed: 24682848
HIV AIDS (Auckl). 2019 Dec 02;11:321-332
pubmed: 31819663
AIDS Care. 1995;7(2):229-5
pubmed: 7619875
J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S228-32
pubmed: 23764640
PLoS Med. 2017 Nov 14;14(11):e1002433
pubmed: 29136001
AIDS. 2012 Oct 23;26(16):2059-67
pubmed: 22781227
PLoS One. 2016 Mar 23;11(3):e0150970
pubmed: 27008536
BMC Health Serv Res. 2020 May 11;20(1):404
pubmed: 32393224
AIDS Behav. 2018 Mar;22(3):722-732
pubmed: 28643242
Patient Educ Couns. 2016 Jul;99(7):1079-1086
pubmed: 26899632
West J Nurs Res. 1998 Aug;20(4):431-47
pubmed: 9686522
Clin Infect Dis. 2015 Apr 1;60(7):1120-7
pubmed: 25516189
BMJ Open. 2019 Dec 15;9(12):e030701
pubmed: 31843823
Nature. 2015 Dec 3;528(7580):S77-85
pubmed: 26633769
J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):334-41
pubmed: 17514019
J Int AIDS Soc. 2012 Nov 19;15(2):17383
pubmed: 23199799
AIDS Behav. 2018 May;22(5):1688-1698
pubmed: 29159595
J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):116-9
pubmed: 22595872
J Gen Intern Med. 2007 Dec;22 Suppl 3:391-5
pubmed: 18026807
AIDS Behav. 2015 Apr;19(4):704-14
pubmed: 25304330
Clin Infect Dis. 2014 Jul;59 Suppl 1:S21-7
pubmed: 24926028
AIDS Care. 2013;25(12):1485-90
pubmed: 23477286
BMC Public Health. 2018 Aug 10;18(1):1003
pubmed: 30097027
Diabetes Care. 2012 Jun;35(6):1364-79
pubmed: 22517736
AIDS Patient Care STDS. 2014 Mar;28(3):136-43
pubmed: 24568654
Afr J AIDS Res. 2012 Mar;11(1):65-73
pubmed: 25870899
AIDS. 2017 Jul 1;31 Suppl 3:S253-S260
pubmed: 28665883
Trop Med Int Health. 2014 Apr;19(4):459-68
pubmed: 24495307
PLoS One. 2013 Nov 25;8(11):e81044
pubmed: 24282566